Market Cap 518.37M
Revenue (ttm) 4.63M
Net Income (ttm) -201.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,344.28%
Debt to Equity Ratio 0.00
Volume 3,501,600
Avg Vol 2,464,004
Day's Range N/A - N/A
Shares Out 180.62M
Stochastic %K 80%
Beta 2.31
Analysts Strong Sell
Price Target $6.92

Company Profile

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States. Its lead therapeutic product candidate is PM359 for Chronic Granulomatous Disease, which is in Phase 1/2 clinical trial; PM577 for Wilson Disease, that is in preclinical studies; and PM647 to treat genetic disorder caused by mutations in the SERPINA1 gene, resulting in production of misfolded Z-AAT protein that accum...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 465 0013
Address:
60 First Street, Cambridge, United States
PorkchopSquats
PorkchopSquats Jun. 19 at 1:52 PM
$PRME Daily candles. Been monitoring this trendline, yesterday was the first day where the entire daily candle’s body was above it since this peaked in November. Might mean nothing, but curious to see if it holds next week. Still beneath the 50MA, still needs to break and hold above that before bulls can see a glimmer of hope in the short term.
0 · Reply
dbagging
dbagging Jun. 18 at 1:42 PM
$PRME 101k at 3.36. Cute
0 · Reply
parcha
parcha Jun. 18 at 12:28 PM
$PRME https://finance.yahoo.com/healthcare/articles/prime-medicine-announces-zealand-clearance-120000321.html
2 · Reply
DARKP00L
DARKP00L Jun. 18 at 12:23 PM
$PRME 08:08 on Jun. 18 2026 Prime Medicine Receives New Zealand's Regulator Clearance For Its Clinical Trial Application For PM577a To Treat Wilson Disease #tradeideas
0 · Reply
PorkchopSquats
PorkchopSquats Jun. 18 at 9:24 AM
$PRME Let’s try this again. 50MA now at $3.31. Not getting excited until this can hold above that for longer than a few hours.
1 · Reply
dbagging
dbagging Jun. 18 at 12:34 AM
1 · Reply
DOGBIRD
DOGBIRD Jun. 17 at 6:02 PM
$PRME My precious. LONNNGGGGG.
0 · Reply
AcceleratorModel
AcceleratorModel Jun. 17 at 4:18 PM
$PRME sold some
0 · Reply
inflect1on
inflect1on Jun. 17 at 4:17 PM
$PRME 30% trim at 3.24 for cash flow, core untouched
0 · Reply
Mindegap
Mindegap Jun. 17 at 2:12 PM
$PRME $QURE news can not be a bad thing here.
0 · Reply
Latest News on PRME
Prime Medicine Transcript: AGM 2026

Jun 5, 2026, 2:00 PM EDT - 14 days ago

Prime Medicine Transcript: AGM 2026


Prime Medicine Slides: Corporate presentation

Jun 3, 2026, 7:00 AM EDT - 16 days ago

Prime Medicine Slides: Corporate presentation


Prime Medicine reports Q1 EPS (28c), consensus (25c)

2026-05-07T19:46:03.000Z - 6 weeks ago

Prime Medicine reports Q1 EPS (28c), consensus (25c)


Prime Medicine Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 6 weeks ago

Prime Medicine Quarterly report: Q1 2026


Prime Medicine Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 6 weeks ago

Prime Medicine Earnings release: Q1 2026


Prime Medicine management to meet with Oppenheimer

2026-05-07T02:02:00.000Z - 6 weeks ago

Prime Medicine management to meet with Oppenheimer


Prime Medicine Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

Prime Medicine Proxy statement: Proxy filing


Prime Medicine Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

Prime Medicine Proxy statement: Proxy filing


Prime Medicine appoints Makhni as Chief Financial Officer

2026-04-16T12:25:29.000Z - 2 months ago

Prime Medicine appoints Makhni as Chief Financial Officer


Prime Medicine initiated with an Outperform at Oppenheimer

2026-03-12T10:26:58.000Z - 3 months ago

Prime Medicine initiated with an Outperform at Oppenheimer


Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year

2026-03-03T13:07:13.000Z - 3 months ago

Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year


Prime Medicine Annual report: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

Prime Medicine Annual report: Q4 2025


Prime Medicine Earnings release: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

Prime Medicine Earnings release: Q4 2025


Prime Medicine Slides: Corporate presentation

Mar 2, 2026, 7:00 AM EST - 3 months ago

Prime Medicine Slides: Corporate presentation


Prime Medicine to Participate in Upcoming Investor Conferences

Feb 25, 2026, 8:00 AM EST - 4 months ago

Prime Medicine to Participate in Upcoming Investor Conferences


Prime Medicine initiated with an Outperform at LifeSci Capital

2025-12-23T13:50:25.000Z - 6 months ago

Prime Medicine initiated with an Outperform at LifeSci Capital


Prime Medicine announces NEJM publication of PM359 data

2025-12-07T18:30:05.000Z - 6 months ago

Prime Medicine announces NEJM publication of PM359 data


Prime Medicine transferred with Neutral rating at JPMorgan

2025-11-18T12:55:59.000Z - 7 months ago

Prime Medicine transferred with Neutral rating at JPMorgan


Prime Medicine Transcript: KOL Event

Nov 12, 2025, 8:00 AM EST - 7 months ago

Prime Medicine Transcript: KOL Event


Prime Medicine Press release: KOL Event

Nov 12, 2025, 8:00 AM EST - 7 months ago

Prime Medicine Press release: KOL Event


Prime Medicine Slides: KOL Event

Nov 12, 2025, 8:00 AM EST - 7 months ago

Prime Medicine Slides: KOL Event


Prime Medicine price target lowered to $4.25 from $5 at Citi

2025-11-11T11:36:03.000Z - 7 months ago

Prime Medicine price target lowered to $4.25 from $5 at Citi


Prime Medicine files automatic mixed securities shelf

2025-11-07T13:11:02.000Z - 8 months ago

Prime Medicine files automatic mixed securities shelf


Prime Medicine reports Q3 EPS (32c), consensus (25c)

2025-11-07T12:13:06.000Z - 8 months ago

Prime Medicine reports Q3 EPS (32c), consensus (25c)


Prime Medicine Quarterly report: Q3 2025

Nov 7, 2025, 7:00 AM EST - 8 months ago

Prime Medicine Quarterly report: Q3 2025


Prime Medicine Earnings release: Q3 2025

Nov 7, 2025, 7:00 AM EST - 8 months ago

Prime Medicine Earnings release: Q3 2025


Prime Medicine Slides: Corporate Presentation

Nov 6, 2025, 7:00 AM EST - 8 months ago

Prime Medicine Slides: Corporate Presentation


Prime Medicine appoints Hawryluk as Chief Business Officer

2025-11-03T13:05:05.000Z - 8 months ago

Prime Medicine appoints Hawryluk as Chief Business Officer


Prime Medicine price target raised to $5 from $4 at Citi

2025-10-29T11:27:04.000Z - 8 months ago

Prime Medicine price target raised to $5 from $4 at Citi


Prime Medicine Slides: Corporate Presentation

Sep 17, 2025, 7:00 AM EDT - 9 months ago

Prime Medicine Slides: Corporate Presentation


Prime Medicine Quarterly report: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

Prime Medicine Quarterly report: Q2 2025


Prime Medicine Earnings release: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

Prime Medicine Earnings release: Q2 2025


Prime Medicine Announces Pricing of Public Offering

Jul 30, 2025, 9:33 PM EDT - 11 months ago

Prime Medicine Announces Pricing of Public Offering


Prime Medicine Announces Proposed Public Offering of Common Stock

Jul 30, 2025, 4:01 PM EDT - 11 months ago

Prime Medicine Announces Proposed Public Offering of Common Stock


Prime Medicine Proxy statement: Proxy Filing

Jul 14, 2025, 8:00 AM EDT - 1 year ago

Prime Medicine Proxy statement: Proxy Filing


Prime Medicine Proxy statement: Proxy Filing

Jul 2, 2025, 8:00 AM EDT - 1 year ago

Prime Medicine Proxy statement: Proxy Filing


Prime Medicine Slides: Corporate Presentation

Jun 25, 2025, 7:00 AM EDT - 1 year ago

Prime Medicine Slides: Corporate Presentation


Prime Medicine Proxy statement: Proxy Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

Prime Medicine Proxy statement: Proxy Filing


Prime Medicine Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Prime Medicine Quarterly report: Q1 2025


Prime Medicine Earnings release: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Prime Medicine Earnings release: Q1 2025


Prime Medicine Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Prime Medicine Proxy statement: Proxy Filing


Prime Medicine Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Prime Medicine Proxy statement: Proxy Filing


Prime Medicine Annual report: Q4 2024

Feb 28, 2025, 8:00 AM EST - 1 year ago

Prime Medicine Annual report: Q4 2024


Prime Medicine Earnings release: Q4 2024

Feb 28, 2025, 8:00 AM EST - 1 year ago

Prime Medicine Earnings release: Q4 2024


Prime Medicine Slides: FY 2025

Jan 14, 2025, 6:00 PM EST - 1 year ago

Prime Medicine Slides: FY 2025


Prime Medicine Registration statement: Registration Filing

Dec 13, 2024, 7:00 AM EST - 1 year ago

Prime Medicine Registration statement: Registration Filing


Prime Medicine Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 1:15 PM EST - 1 year ago

Prime Medicine Transcript: Stifel 2024 Healthcare Conference


Prime Medicine Quarterly report: Q3 2024

Nov 12, 2024, 9:30 AM EST - 1 year ago

Prime Medicine Quarterly report: Q3 2024


Prime Medicine Earnings release: Q3 2024

Nov 12, 2024, 9:30 AM EST - 1 year ago

Prime Medicine Earnings release: Q3 2024


Prime Medicine Unveils Strategically Focused Pipeline

Sep 30, 2024, 7:01 AM EDT - 1 year ago

Prime Medicine Unveils Strategically Focused Pipeline


Prime Medicine Quarterly report: Q2 2024

Aug 8, 2024, 8:15 AM EDT - 2 years ago

Prime Medicine Quarterly report: Q2 2024


Prime Medicine Earnings release: Q2 2024

Aug 8, 2024, 8:15 AM EDT - 2 years ago

Prime Medicine Earnings release: Q2 2024


Prime Medicine Proxy statement: Proxy Filing

May 21, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine Proxy statement: Proxy Filing


Alphabet Bought Up Two Slumping Stocks

May 12, 2024, 3:00 AM EDT - 2 years ago

Alphabet Bought Up Two Slumping Stocks

GOOG GOOGL GTLB


Prime Medicine Quarterly report: Q1 2024

May 10, 2024, 7:00 AM EDT - 2 years ago

Prime Medicine Quarterly report: Q1 2024


Prime Medicine Earnings release: Q1 2024

May 10, 2024, 7:00 AM EDT - 2 years ago

Prime Medicine Earnings release: Q1 2024


Prime Medicine Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine Proxy statement: Proxy Filing


Prime Medicine Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine Proxy statement: Proxy Filing


Prime Medicine Proxy statement: Proxy Filing

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine Proxy statement: Proxy Filing


Prime Medicine Earnings release: Q4 2023

Mar 1, 2024, 7:00 AM EST - 2 years ago

Prime Medicine Earnings release: Q4 2023


Prime Medicine Annual report: Q4 2023

Mar 1, 2024, 7:00 AM EST - 2 years ago

Prime Medicine Annual report: Q4 2023


Prime Medicine Announces Pricing of Upsized Public Offering

Feb 14, 2024, 11:50 PM EST - 2 years ago

Prime Medicine Announces Pricing of Upsized Public Offering


Prime Medicine Slides: FY 2024

Jan 8, 2024, 5:15 PM EST - 2 years ago

Prime Medicine Slides: FY 2024


Prime Medicine to Present at Upcoming Investor Conferences

Nov 8, 2023, 8:00 AM EST - 2 years ago

Prime Medicine to Present at Upcoming Investor Conferences


Prime Medicine Quarterly report: Q3 2023

Nov 3, 2023, 8:00 AM EDT - 2 years ago

Prime Medicine Quarterly report: Q3 2023


Prime Medicine Earnings release: Q3 2023

Nov 3, 2023, 8:00 AM EDT - 2 years ago

Prime Medicine Earnings release: Q3 2023


Prime Medicine Registration statement: Registration Filing

Nov 3, 2023, 8:00 AM EDT - 2 years ago

Prime Medicine Registration statement: Registration Filing


Prime Medicine Slides: Corporate Presentation

Sep 7, 2023, 4:00 PM EDT - 3 years ago

Prime Medicine Slides: Corporate Presentation


PorkchopSquats
PorkchopSquats Jun. 19 at 1:52 PM
$PRME Daily candles. Been monitoring this trendline, yesterday was the first day where the entire daily candle’s body was above it since this peaked in November. Might mean nothing, but curious to see if it holds next week. Still beneath the 50MA, still needs to break and hold above that before bulls can see a glimmer of hope in the short term.
0 · Reply
dbagging
dbagging Jun. 18 at 1:42 PM
$PRME 101k at 3.36. Cute
0 · Reply
parcha
parcha Jun. 18 at 12:28 PM
$PRME https://finance.yahoo.com/healthcare/articles/prime-medicine-announces-zealand-clearance-120000321.html
2 · Reply
DARKP00L
DARKP00L Jun. 18 at 12:23 PM
$PRME 08:08 on Jun. 18 2026 Prime Medicine Receives New Zealand's Regulator Clearance For Its Clinical Trial Application For PM577a To Treat Wilson Disease #tradeideas
0 · Reply
PorkchopSquats
PorkchopSquats Jun. 18 at 9:24 AM
$PRME Let’s try this again. 50MA now at $3.31. Not getting excited until this can hold above that for longer than a few hours.
1 · Reply
dbagging
dbagging Jun. 18 at 12:34 AM
1 · Reply
DOGBIRD
DOGBIRD Jun. 17 at 6:02 PM
$PRME My precious. LONNNGGGGG.
0 · Reply
AcceleratorModel
AcceleratorModel Jun. 17 at 4:18 PM
$PRME sold some
0 · Reply
inflect1on
inflect1on Jun. 17 at 4:17 PM
$PRME 30% trim at 3.24 for cash flow, core untouched
0 · Reply
Mindegap
Mindegap Jun. 17 at 2:12 PM
$PRME $QURE news can not be a bad thing here.
0 · Reply
JasonCO
JasonCO Jun. 17 at 2:12 PM
2 · Reply
Floorguy7
Floorguy7 Jun. 17 at 1:53 PM
$PRME 👀
0 · Reply
burbs88
burbs88 Jun. 17 at 12:25 PM
$PRME Data please 🙏
1 · Reply
BIOTECH_GURU
BIOTECH_GURU Jun. 16 at 12:27 AM
$PRME if $CRSP is like changing bad spark plugs, prime is like changing the spark plug with the engine running. This is a highly sophisticated technology that will likely make a lot of noise soon enough. Loading every dip. Nfa. Glta.
0 · Reply
Sunnym_15
Sunnym_15 Jun. 15 at 10:48 PM
$AGEN I hope you guys learn from $ELTX. You are going to become a victim of bagholderitis. The peptide immunotherapy revolution will start with low disease burden settings, and even the failure of $ELTX just reinforced that today. Hopefully, when gene-editing platforms like $PRME establish themselves, or Big Pharma streamlines the process to effectively target tumors, building on top of the WT1 platform that Sellas will establish, all will be well. GLTAL $SLS.
5 · Reply
NewEarth
NewEarth Jun. 15 at 4:34 PM
0 · Reply
srost002
srost002 Jun. 15 at 4:12 PM
$PRME hold some gains for Gods sake
1 · Reply
SirSloth
SirSloth Jun. 15 at 3:36 PM
0 · Reply
NewEarth
NewEarth Jun. 15 at 2:27 PM
0 · Reply
ATTAB0Y
ATTAB0Y Jun. 15 at 1:53 PM
$PRME https://www.broadinstitute.org/news/scientists-improve-nearly-every-aspect-prime-editing-moving-it-closer-treating-more-genetic
0 · Reply
arg195
arg195 Jun. 15 at 1:47 PM
$PRME look at the volume 😂😂 red eod
0 · Reply
NewEarth
NewEarth Jun. 15 at 11:43 AM
0 · Reply